Kazunori Toyoda Selected Research

Glucose (Dextrose)

4/2022	Effect of Moderate and Severe Persistent Hyperglycemia on Outcomes in Patients With Intracerebral Hemorrhage.
12/2018	Outcome Prediction in Acute Stroke Patients by Continuous Glucose Monitoring.
4/2013	NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunori Toyoda Research Topics

Disease

204	Stroke (Strokes) 04/2024 - 01/2004
129	Ischemic Stroke 05/2024 - 05/2003
67	Hemorrhage 02/2024 - 09/2004
61	Atrial Fibrillation 04/2024 - 01/2009
43	Cerebral Hemorrhage 01/2023 - 11/2004
26	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2024 - 01/2004
19	Embolism (Embolus) 01/2024 - 07/2004
18	Transient Ischemic Attack 04/2024 - 08/2015
16	Hypertension (High Blood Pressure) 04/2024 - 01/2004
16	Infarction (Infarctions) 01/2022 - 01/2004
15	Embolic Stroke 01/2024 - 02/2014
15	Hematoma 01/2023 - 05/2003
9	Thrombosis (Thrombus) 01/2024 - 01/2002
8	Myocardial Infarction 08/2023 - 01/2017
7	Heart Failure 01/2024 - 11/2009
7	COVID-19 01/2023 - 01/2020
7	Body Weight (Weight, Body) 11/2022 - 11/2014
7	Atherosclerosis 02/2021 - 07/2007
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2024 - 07/2010
6	Diabetes Mellitus 02/2024 - 01/2006
6	Pathologic Constriction (Stenosis) 01/2023 - 01/2006
6	Hemorrhagic Stroke 01/2022 - 06/2008
5	Epilepsy (Aura) 01/2023 - 03/2014
5	Cerebral Infarction 01/2022 - 06/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 06/2008
4	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2008
4	Infections 01/2020 - 01/2015
3	Brain Infarction 01/2024 - 05/2003
3	Lacunar Stroke 01/2023 - 05/2012
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2023 - 07/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 01/2013
3	Chronic Renal Insufficiency 11/2022 - 08/2014
3	Hyperglycemia 04/2022 - 11/2009
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 04/2012
3	Aortic Dissection 08/2018 - 01/2015
3	Carotid Artery Diseases 01/2018 - 07/2007
3	Paresis (Hemiparesis) 08/2016 - 09/2005
3	Ischemia 01/2016 - 02/2011
3	Thromboembolism 12/2015 - 01/2012
2	Cerebral Small Vessel Diseases 12/2023 - 01/2022
2	Inflammation (Inflammations) 11/2023 - 03/2018
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2023 - 01/2004
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2023 - 01/2019
2	Neoplasms (Cancer) 05/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

70	AnticoagulantsIBA 04/2024 - 05/2003
54	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 01/2009
33	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 06/2008
23	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 11/2003
15	RivaroxabanIBA 10/2022 - 01/2013
14	Clopidogrel (Plavix)FDA Link 06/2023 - 02/2015
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2023 - 01/2009
12	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2015
12	Vitamin K FDA Link 01/2023 - 04/2012
11	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2024 - 06/2008
11	fibrin fragment D (D-dimer)IBA 08/2023 - 01/2010
11	Nicardipine (Dagan)FDA LinkGeneric 01/2023 - 01/2012
10	CreatinineIBA 11/2023 - 01/2006
10	Dabigatran FDA Link 10/2022 - 04/2012
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 04/2010
9	Cilostazol (Pletal)FDA LinkGeneric 06/2023 - 02/2015
8	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2008
7	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023 - 06/2008
7	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2004
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2023 - 02/2015
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2006
5	apixabanIBA 10/2022 - 01/2016
5	Prasugrel Hydrochloride FDA Link 02/2021 - 04/2018
4	Hemostatics (Antihemorrhagics)IBA 08/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
4	Blood Glucose (Blood Sugar)IBA 12/2018 - 01/2009
3	CollagenIBA 11/2023 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 04/2013
3	Thrombin FDA Link 01/2022 - 11/2020
3	recombinant FVIIa (rFVIIa)FDA Link 01/2022 - 01/2021
3	LipidsIBA 10/2021 - 01/2012
3	Factor Xa InhibitorsIBA 01/2021 - 04/2012
3	Pravastatin (Pravachol)FDA LinkGeneric 01/2019 - 03/2017
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 08/2016 - 01/2012
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
2	Cytochrome P-450 CYP2C19IBA 01/2023 - 01/2019
2	edoxabanIBA 10/2022 - 12/2019
2	FibrinIBA 05/2022 - 01/2018

Therapy/Procedure

125	Therapeutics 05/2024 - 05/2003
30	Thrombectomy 01/2023 - 01/2014
17	Secondary Prevention 04/2024 - 01/2009
7	Carotid Endarterectomy 01/2023 - 10/2005
7	Renal Dialysis (Hemodialysis) 12/2022 - 01/2004
5	Catheter Ablation 11/2023 - 12/2019
5	Thrombolytic Therapy 04/2016 - 01/2002
4	Stents 01/2023 - 06/2015
4	Drug Therapy (Chemotherapy) 01/2016 - 01/2009
3	Polypharmacy 01/2024 - 12/2022
3	Aftercare (After-Treatment) 01/2019 - 01/2013
3	Treatment Delay 08/2016 - 11/2014
2	Punctures 08/2023 - 01/2022
2	Percutaneous Coronary Intervention 01/2023 - 01/2020
2	Catheters 01/2023 - 03/2019